Loading...
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC)
Epidermal growth factor receptor (EGFR) is usually expressed in squamous cell anal carcinoma (SCAC) and anti-EGFR agents could represent a valid treatment strategy, also considering that KRAS and BRAF mutations are rare events in this type of cancer. However, no data are available on NRAS status in...
Na minha lista:
Udgivet i: | Sci Rep |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Nature Publishing Group
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122846/ https://ncbi.nlm.nih.gov/pubmed/27886225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep37621 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|